Analysis of 1184 gene transcript levels in Alzheimer CA1 hippocampus: Synaptic signaling and transcription factor deficits and upregulation of pro-inflammatory pathways

Alzheimer's Reports

Volumn 3, Issue 3, 2000, Pages 161-167

  Lukiw, Walter J ^a   Carver, Larry A ^a   Leblanc, Hector J ^a   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746673176     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Colantuoni C, Purcell AE, Bouton CM and Pevsner J (2000). High throughput analysis of gene expression in the human brain. J Neurvsc Res 59, 1-10.
2. Czech C, Tremp G and Pradier L (2000). Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog NeumbiolQb, 363-384.
3. Heffernan JM, Eastwood SL, Nagy Z étal. (1998). Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Exp Neurol 150,235-239.
4. Heyman A, Fillenbaum GG, Welsh-Bohmer KA e/s/(1998). Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVlll. Consortium to Establish a Registry for Alzheimer's Disease. Neurology5, 159-162.
5. Khodarev NN, Advani SJ, Gupta N étal. (1999). Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc NatlAcadSci USA 96,12062-12067.
6. Kitamura Y, Shimohama S, Koike H étal. (1999). Increased expression of cyclo-oxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem. Biophys Res CommïtA. 582-586.
7. Lichtlen P, Georgiev O, Schaffner W étal. (1999). The heavy metalresponsive transcription factor-1 (MTF-1 ). is not required for neural differentiation. JBiolChemyVb, 711-715.
8. Lipshutz RJ, Fodor SP, Gingeras TR and Lockhart DJ (1999). High density synthetic oligonucleotide arrays. NatGenetï, 20-24.
9. Lukiw WJ, Rogaev El and Bazan NG (1996). Synaptic and cytoskeletal RNA message levels in sporadic Alzheimer neocortex. AIzRes 2,221-227.
10. Lukiw WJ and Bazan NG (1998). Strong nuclear factor-kappaB-DNA binding parallels cycIo-oxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. JNeurosci Res 53,583-592.
11. Lukiw WJ, Martinez J, Palacios-Pelaez R and Bazan NG (1998). The interleukin-1 type 2 receptor gene displays immediate early gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes. JBiolChemïH, 8630-8638.
12. Mattson MP, Culmsee C, Yu Z and Camandola S (2000). Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neumchemll, 443-456.
13. McGeer EG and McGeer PL (1999). Brain inflammation in Alzheimer disease and the therapeutic implications. CurrPharm Res 10, 821-836.
14. Newell KL, Hyman BT, Growdon JH and Hedley-Whyte ET (1999). Application of the National Institute on Aging (NIA).-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. JNeuropatholExp NeurolSb, 1147-1155.
15. Nguyen Ba-Charvet KT, Brose K, Marillat V etal. (1999). Slit2-Mediated chemorepulsion and collapse of developing forebrain axons. Neuron 22,463-473.
16. Oohira A, Matsui F, Tokita Y et al. (2000). Molecularinteractions of neural chondroitin sulfate proteoglycans in brain development/1/rA Biochem. B/op/7ys374,24-34.
17. Price DL, Tanzi RE, Borchelt DR and Sisodia SS (1998). Alzheimer's disease: genetic studies and transgenic models. Ann Rev Genet 32,461-493.
18. Rogaev El, Sherrington R, Wu C eta!. (1997). Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1). associated with early onset Alzheimer disease. Genomics40,415-424.
19. Ross J (1996). Control of messenger RNA stability in higher eukaryotes. Trends GenetS, 171-175.
20. St. George-Hyslop PH (2000). Molecular genetics of Alzheimer's disease. Biol Psychiatr47', 183-199.
21. Scheff SW and Price DA (1998). Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J Neuropathol Exp Neurol 57, 1146-1153.
22. Toi J, Roks G, Slooter AJ and van Duijn CM (1999). Genetic and environmental factors in Alzheimer's disease. Rev Neurol 155,10-16.
23. Van Leeuwen FW, de Kleijn DP, van den Hurk HH etal. (1998). Frameshift mutants of beta amyloid precursor protein and ubiquitinB in Alzheimer's and Down patients. Sc/ence279,242-247.
24. Wheal HV, Chen Y, Mitchell J etal. (1998). Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog Neurobiol 55, 611-640.